Your browser is no longer supported. Please, upgrade your browser.
Settings
TSRO Tesaro, Inc. daily Stock Chart
TSRO [NASD]
Tesaro, Inc.
Index- P/E- EPS (ttm)-11.91 Insider Own0.20% Shs Outstand67.79M Perf Week-17.57%
Market Cap1.76B Forward P/E- EPS next Y-9.02 Insider Trans-11.59% Shs Float53.25M Perf Month-40.12%
Income-648.60M PEG- EPS next Q-2.43 Inst Own- Short Float23.68% Perf Quarter-4.52%
Sales219.40M P/S8.03 EPS this Y-16.80% Inst Trans5.07% Short Ratio7.09 Perf Half Y-48.62%
Book/sh-2.38 P/B- EPS next Y18.00% ROA-83.30% Target Price55.28 Perf Year-70.03%
Cash/sh7.03 P/C3.70 EPS next 5Y19.00% ROE- 52W Range23.41 - 90.50 Perf YTD-68.64%
Dividend- P/FCF- EPS past 5Y-15.30% ROI-70.10% 52W High-71.28% Beta1.36
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin66.40% 52W Low11.02% ATR3.21
Employees715 Current Ratio3.40 Sales Q/Q-54.90% Oper. Margin- RSI (14)37.88 Volatility15.63% 11.05%
OptionableYes Debt/Eq- EPS Q/Q-435.30% Profit Margin- Rel Volume1.35 Prev Close29.29
ShortableYes LT Debt/Eq- EarningsNov 01 AMC Payout- Avg Volume1.78M Price25.99
Recom2.10 SMA20-20.59% SMA50-27.92% SMA200-42.15% Volume2,405,804 Change-11.27%
Oct-01-18Initiated Cantor Fitzgerald Overweight $57
Sep-25-18Initiated Leerink Partners Outperform
Aug-15-18Downgrade Argus Buy → Hold
Aug-06-18Downgrade BofA/Merrill Buy → Neutral
May-07-18Reiterated Lake Street Buy $120 → $80
Feb-28-18Reiterated Barclays Equal Weight $135 → $90
Feb-22-18Upgrade Evercore ISI In-line → Outperform
Jan-18-18Reiterated Credit Suisse Outperform $190 → $150
Jan-16-18Reiterated Morgan Stanley Overweight $165 → $156
Dec-20-17Reiterated Citigroup Buy $216 → $135
Nov-15-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-23-17Resumed Piper Jaffray Neutral $117
Oct-23-17Initiated Barclays Equal Weight $135
Oct-12-17Initiated H.C. Wainwright Buy $158
Aug-17-17Initiated Evercore ISI In-line $121
Jul-07-17Initiated Gabelli & Co Buy $175
Jun-05-17Reiterated FBR & Co. Mkt Perform $200 → $195
May-10-17Reiterated FBR & Co. Mkt Perform $202 → $200
Apr-12-17Initiated Piper Jaffray Overweight $180
Apr-10-17Initiated Janney Neutral $141
Nov-14-18 04:04PM  SHAREHOLDER ALERT: APOG COCP COST TRVN HON DY ALGN AQUA SONS TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire -11.27%
10:28AM  Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA Zacks
09:32AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: January 9, 2019 ACCESSWIRE
09:30AM  Election Night Cannabis Approvals Could Benefit These Companies ACCESSWIRE
Nov-13-18 01:41PM  AstraZeneca's Lynparza Gets Priority Review in 1st Line Use Zacks +8.44%
Nov-12-18 05:27PM  CLASS ACTION UPDATE for IGCC, ALGN, AQUA and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire +7.61%
09:32AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline - January 9, 2019 ACCESSWIRE
08:53AM  Do Options Traders Know Something About TESARO (TSRO) Stock We Don't? Zacks
Nov-09-18 08:02PM  Pomerantz Law Firm Announces the Filing of a Class Action against Tesaro, Inc. and Certain Officers TSRO GlobeNewswire -18.80%
05:21PM  Here's Why AnaptysBio, Inc. Slipped on Friday Motley Fool
03:41PM  TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting GlobeNewswire
01:28PM  AnaptysBio Inc. Sets Up More Shots on Goal in the Third Quarter Motley Fool
Nov-07-18 09:31PM  Edited Transcript of TSRO earnings conference call or presentation 1-Nov-18 8:15pm GMT Thomson Reuters StreetEvents +7.24%
Nov-02-18 02:53PM  TESARO (TSRO) Q3 Earnings Beat, Revenues Miss, Shares Up Zacks
08:01AM  The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug Benzinga
Nov-01-18 06:20PM  Tesaro (TSRO) Reports Q3 Loss, Lags Revenue Estimates Zacks +10.39%
05:14PM  Tesaro: 3Q Earnings Snapshot Associated Press
04:05PM  TESARO Announces Third-Quarter 2018 Operating Results GlobeNewswire
Oct-30-18 08:05AM  The Foundation for Womens Cancer and TESARO Partner on the Race to End Womens Cancer for 3rd Year GlobeNewswire
Oct-29-18 08:00AM  TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen GlobeNewswire
Oct-24-18 06:49PM  Here's Why Tesaro Inc. Dropped 13.8% Today Motley Fool -13.82%
08:35AM  Factors of Influence in 2018, Key Indicators and Opportunity within YRC Worldwide, NRG Energy, TESARO, The Trade Desk, Foot Locker, and Hertz Global New Research Emphasizes Economic Growth GlobeNewswire
08:00AM  TESARO and Actress Cobie Smulders Launch Not on My Watch, a National Movement to Empower the Ovarian Cancer Community GlobeNewswire
Oct-23-18 08:00AM  Todays Research Reports on Stocks to Watch: Tesaro and Nektar Therapeutics ACCESSWIRE
Oct-22-18 04:26PM  These Companies Are Dragging Biotech Stocks Into A Pit On Cancer Tests Investor's Business Daily -11.57%
04:23PM  Why Tesaro, Inc. Is Tanking Today Motley Fool
06:00AM  3 Biotech Stocks Poised to Rise by 15% or More Investopedia
Oct-20-18 01:30AM  TESARO Announces Data Presentations at ESMO 2018 Congress GlobeNewswire
Oct-18-18 04:15PM  TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018 GlobeNewswire
04:01PM  Tesaro Bulls Double Their Money TheStreet.com
Oct-17-18 08:00AM  Today's Research Reports on Trending Tickers: BioMarin Pharmaceutical and Tesaro ACCESSWIRE
Oct-15-18 08:00AM  Today's Research Reports on Trending Tickers: Tesaro and Neurocrine Biosciences ACCESSWIRE
Oct-10-18 10:35AM  Biotech Gearing Up for a Pullback? Investopedia
Oct-09-18 08:15AM  TESARO Announces Data Presentations at the ESMO 2018 Congress GlobeNewswire
Oct-05-18 08:53AM  Do Options Traders Know Something About Tesaro (TSRO) Stock We Don't? Zacks
Oct-04-18 08:00AM  Today's Research Reports on Trending Tickers: Tesaro and Sarepta Therapeutics ACCESSWIRE
Oct-01-18 06:15PM  TESARO Announces Data Presentations at the SITC 2018 Annual Meeting GlobeNewswire
Sep-24-18 10:19AM  3 Ways to Unpack Some Hidden Treasure in Tesaro Stock InvestorPlace
Sep-20-18 08:00AM  Today's Research Reports on Trending Tickers: Acceleron Pharma and Tesaro ACCESSWIRE
Sep-19-18 04:15PM  TESARO Announces Participation at Two Investor Conferences GlobeNewswire
Sep-17-18 08:37AM  Options Traders Expect Huge Moves in Tesaro (TSRO) Stock Zacks
Sep-07-18 08:00AM  How Tesaro Hopes to Tackle Lung Cancer Motley Fool
Sep-06-18 08:57AM  Tesaro (TSRO) Surges: Stock Moves 5.5% Higher Zacks
Sep-05-18 04:17PM  This Biotech Got A Bullish Pop On Its Experimental Cancer Regimen Investor's Business Daily +5.46%
Sep-04-18 04:15PM  TESARO Announces Expansion to Second Stage of JASPER Trial of ZEJULA® in Combination With TSR-042 in Non-Small Cell Lung Cancer GlobeNewswire
Aug-27-18 08:00AM  TESARO Announces Participation at Three Investor Conferences GlobeNewswire +6.64%
Aug-15-18 05:34AM  Edited Transcript of TSRO earnings conference call or presentation 2-Aug-18 8:15pm GMT Thomson Reuters StreetEvents
Aug-06-18 08:49AM  Is the Options Market Predicting a Spike in Tesaro (TSRO) Stock? Zacks
08:00AM  Todays Research Reports on Stocks to Watch: Tesaro and Stericycle ACCESSWIRE
Aug-03-18 04:44PM  Why Shake Shack, Tesaro, and Square Slumped Today Motley Fool -23.55%
04:09PM  Tesaro CEO Says Its Drug 'Will Get There' Analysts Strongly Disagree Investor's Business Daily
03:27PM  A Disappointment Is Sinking Tesaro Shares Today Motley Fool
11:36AM  Tesaro stock drops 16% on worse-than-expected Q2 results, downbeat guidance MarketWatch
10:22AM  TESARO (TSRO) Misses Earnings and Revenue Estimates in Q2 Zacks
08:00AM  Today's Research Reports on Trending Tickers: Tesaro and MannKind ACCESSWIRE
Aug-02-18 08:05PM  Tesaro (TSRO) Reports Q2 Loss, Lags Revenue Estimates Zacks
07:02PM  Tesaro: 2Q Earnings Snapshot Associated Press
04:05PM  TESARO Announces Second-Quarter 2018 Operating Results GlobeNewswire
02:15PM  TESARO, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 09:31PM  Is Opko Health Getting Its Mojo Back? Motley Fool
Jul-20-18 04:15PM  TESARO to Announce Second-Quarter 2018 Financial Results on August 2, 2018 GlobeNewswire
Jul-08-18 06:31AM  The 3 Worst Biotech Stocks of 2018 (So Far) Motley Fool
Jul-04-18 08:00AM  Today's Research Reports on Trending Tickers: Tesaro and REGENXBIO ACCESSWIRE
Jul-02-18 09:00AM  TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute GlobeNewswire -6.54%
Jun-29-18 04:05PM  TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing GlobeNewswire
Jun-28-18 04:05PM  TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada GlobeNewswire
Jun-27-18 11:42AM  Analysts Expect Breakeven For Tesaro Inc (NASDAQ:TSRO) Simply Wall St.
08:55AM  Implied Volatility Surging for Tesaro (TSRO) Stock Options Zacks
Jun-21-18 09:08AM  TESARO (TSRO) Stock Up on Rumors of Buyout Offer From Roche Zacks
08:15AM  Today's Research Reports on Stocks to Watch: Anika Therapeutics and Tesaro ACCESSWIRE
07:15AM  Will Roche's (RHHBY) Acquisition Spree Revive the Top Line? Zacks
Jun-20-18 04:32PM  Why Winnebago Industries, Synaptics, and Tesaro Jumped Today Motley Fool +16.25%
02:39PM  Why Tesaro Is Skyrocketing 14.2% Today Motley Fool
Jun-18-18 07:45AM  Recent Analysis Shows Enel Américas, ZAGG, DCT Industrial Trust, Community Healthcare Trust, Wabash National, and Tesaro Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jun-12-18 07:48AM  Loss-Making Tesaro Inc (NASDAQ:TSRO) Expected To Breakeven Simply Wall St.
Jun-07-18 08:20AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and Tesaro ACCESSWIRE
Jun-06-18 08:57AM  TESARO Collaborates With Roche to Develop Zejula Combination Zacks
Jun-05-18 08:30AM  TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer GlobeNewswire
Jun-04-18 06:00PM  TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting GlobeNewswire -9.83%
Jun-01-18 08:30AM  Today's Research Reports on Trending Tickers: Tesaro and Agios Pharmaceuticals ACCESSWIRE
03:02AM  TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK GlobeNewswire
May-30-18 03:50PM  5 Top Stock Trades for Thursday Morning InvestorPlace -10.42%
May-29-18 08:30AM  Today's Research Reports on Trending Tickers: Tesaro and TherapeuticsMD ACCESSWIRE
May-23-18 08:00AM  Today's Research Reports on Trending Tickers: Tesaro and Exelixis ACCESSWIRE
May-22-18 09:15PM  Is This Stock the Next Biotech Acquisition Target? Motley Fool
11:23AM  How Confident Are Insiders About Tesaro Inc (NASDAQ:TSRO)? Simply Wall St.
May-21-18 07:25AM  Stock Performance Review on Tesaro and Three Other Biotech Industry ACCESSWIRE
May-16-18 05:15PM  TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
May-10-18 03:23PM  Former Biotech Darlings Tesaro, Clovis Pin Hopes on 2018 Rebound Bloomberg
May-09-18 02:27PM  With A -24.35% Earnings Drop, Is Tesaro Incs (NASDAQ:TSRO) A Concern? Simply Wall St.
May-08-18 09:25AM  Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients GlobeNewswire
09:19AM  Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients GlobeNewswire
May-07-18 06:10AM  Edited Transcript of TSRO earnings conference call or presentation 3-May-18 8:15pm GMT Thomson Reuters StreetEvents -6.00%
May-04-18 08:16AM  Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down Benzinga
May-03-18 05:40PM  Tesaro Dives After First-Quarter Sales Lag On Wider-Than-Expected Losses Investor's Business Daily -5.06%
04:41PM  Tesaro: 1Q Earnings Snapshot Associated Press
04:05PM  TESARO Announces First-Quarter 2018 Operating Results GlobeNewswire
May-01-18 04:15PM  TESARO Announces Participation in Two Investor Conferences GlobeNewswire
Apr-24-18 07:00AM  TESARO Announces Positive Top-Line Results From Quadra Trial of ZEJULA® GlobeNewswire
Apr-19-18 04:15PM  TESARO to Announce First-Quarter 2018 Financial Results on May 3, 2018 GlobeNewswire
Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States. It offers ZEJULA (niraparib), an orally active and potent poly polymerase inhibitor for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer; and VARUBI (rolapitant), a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. The company also develops Niraparib for the treatment of various tumors. In addition, it is developing immunotherapy antibody product candidates, including TSR-042, which is in a phase I clinical trial targeting programmed cell death protein 1; TSR-022 that is in phase I clinical trial targeting T-cell immunoglobulin domain and mucin domain-3; and TSR-033, an antibody candidate, which is in phase I clinical trial targeting lymphocyte-activation gene-3. The company has collaboration and exclusive license agreement with AnaptysBio, Inc., as well as collaboration agreements with Janssen Biotech, Inc., Millennium Pharmaceuticals, Inc., Zai Lab (Shanghai) Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd., Merck Sharp & Dohme B.V., and Jiangsu Hengrui Medicine Co., Ltd., as well as Genentech. Tesaro, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huber Martin H. Jr.SVP & Chief Medical OfficerSep 24Sale37.6337113,96112,206Sep 25 06:00 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerSep 21Option Exercise0.001,250012,577Sep 25 06:00 PM
Oliveira OrlandoSVP & GM, InternationalSep 04Sale32.44722,33610,254Sep 05 05:04 PM
Oliveira OrlandoSVP & GM, InternationalSep 01Option Exercise0.001,250010,326Sep 05 05:04 PM
ORONSKY ARNOLD LDirectorAug 07Option Exercise0.0010,000012,479Aug 09 02:00 PM
ORONSKY ARNOLD LDirectorAug 07Sale26.7710,000267,7212,479Aug 09 02:00 PM
Farmer Joseph LSr VP, Gen Counsel & SecretaryAug 01Option Exercise0.0062508,479Aug 03 05:00 PM
Farmer Joseph LSr VP, Gen Counsel & SecretaryAug 01Sale34.371876,4278,292Aug 03 05:00 PM
Alleva Lawrence MDirectorJun 12Option Exercise6.627,14247,24437,044Jun 14 04:14 PM
Alleva Lawrence MDirectorJun 12Sale43.117,142307,92029,902Jun 14 04:14 PM
Oliveira OrlandoSVP & GM, InternationalMar 08Sale69.883,000209,6409,076Mar 09 05:14 PM
MOTT DAVID MDirectorMar 06Buy59.8215,793944,6659,681,129Mar 06 09:20 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 06Buy59.8212,634755,7089,681,129Mar 06 09:19 PM
Viswanathan Ravi10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:16 PM
SANDELL SCOTT D10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:17 PM
BASKETT FOREST10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:11 PM
KERINS PATRICK J10% OwnerMar 06Buy59.8212,634755,7089,681,129Mar 06 09:11 PM
BARRETT M JAMES10% OwnerMar 06Buy59.8212,634755,7089,681,129Mar 06 09:10 PM
BARRIS PETER J10% OwnerMar 06Buy59.8215,793944,6659,681,129Mar 06 09:10 PM
MOTT DAVID MDirectorMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:20 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 05Buy58.8349,1692,892,6009,668,495Mar 06 09:19 PM
Viswanathan Ravi10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:16 PM
SANDELL SCOTT D10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:17 PM
BASKETT FOREST10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:11 PM
KERINS PATRICK J10% OwnerMar 05Buy58.8349,1692,892,6009,668,495Mar 06 09:11 PM
BARRETT M JAMES10% OwnerMar 05Buy58.8349,1692,892,6009,668,495Mar 06 09:10 PM
BARRIS PETER J10% OwnerMar 05Buy58.8361,4373,614,3359,668,495Mar 06 09:10 PM
MOULDER LEON O JRChief Executive OfficerMar 02Buy56.935,000284,6405,000Mar 05 06:05 AM
MOTT DAVID MDirectorMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:20 PM
NEW ENTERPRISE ASSOCIATES 13 L10% OwnerMar 02Buy55.5654,6423,036,1699,619,326Mar 06 09:19 PM
Viswanathan Ravi10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:16 PM
SANDELL SCOTT D10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:17 PM
BASKETT FOREST10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:11 PM
KERINS PATRICK J10% OwnerMar 02Buy55.5654,6423,036,1699,619,326Mar 06 09:11 PM
BARRETT M JAMES10% OwnerMar 02Buy55.5654,6423,036,1699,619,326Mar 06 09:10 PM
BARRIS PETER J10% OwnerMar 02Buy55.5668,3023,795,1859,619,326Mar 06 09:10 PM
Farmer Joseph LSr.VP,Gen.Counsel & SecretaryMar 02Sale54.862,634144,5017,854Mar 05 05:26 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerMar 02Sale54.861,80398,91311,327Mar 05 05:25 PM
PEARSON TIMOTHY RExec. VP, CFOMar 02Sale54.862,575141,2656,211Mar 05 05:23 PM
Oliveira OrlandoSVP & GM, InternationalMar 02Sale54.8633718,48812,076Mar 05 05:25 PM
Hedley Mary LynnePresident & COOMar 01Option Exercise0.0012,780018,853Mar 05 05:24 PM
Bogle Grant C.Sr. VP, Chief Commercial Ofc.Mar 01Option Exercise0.005,85806,240Mar 05 05:27 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerMar 01Option Exercise0.005,858013,130Mar 05 05:25 PM
PEARSON TIMOTHY RExec. VP, CFOMar 01Option Exercise0.005,85808,786Mar 05 05:23 PM
Oliveira OrlandoSVP & GM, InternationalMar 01Option Exercise0.005,858012,413Mar 05 05:25 PM
MOULDER LEON O JRChief Executive OfficerMar 01Option Exercise0.0015,83601,034,664Mar 05 05:27 PM
Farmer Joseph LSr.VP,Gen.Counsel & SecretaryMar 01Option Exercise0.005,858010,488Mar 05 05:26 PM
Bogle Grant C.Sr. VP, Chief Commercial Ofc.Mar 01Sale54.851,80999,2244,431Mar 05 05:27 PM
Hedley Mary LynnePresident & COOMar 01Sale54.863,855211,48514,998Mar 05 05:24 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerDec 04Sale85.2482970,6647,272Dec 05 06:10 PM
Huber Martin H. Jr.SVP & Chief Medical OfficerDec 01Option Exercise0.001,75008,101Dec 05 06:10 PM